European Efforts in Nanoinformatics Research Applied to Nanomedicine

Nanomedicine and nanoinformatics are emerging disciplines with substantial challenges ahead. For instance, nanomedicine involves complex and massive data analysis. Nanoinformatics could expand previous experiences in Biomedical Informatics with new features required to study different scientific biological and physical characteristics at a different level of complexity. ACTION-Grid is a project, funded by the European Commission, which aims to the creation of a collaborative environment in biomedical and nanomedical research among countries in Europe, Western Balkans, Latin America and North Africa. In this paper, we briefly review the concepts of nanomedicine and nanoinformatics and then we describe the activities of some of the ACTION-Grid consortium members considering those initiatives related to nanomedicine.

[1]  Victor Maojo,et al.  Action GRID: assessing the impact of Nanotechnology on biomedical informatics. , 2008, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[2]  Nicolette de Keizer,et al.  STARE-HI -Statement on Reporting of Evaluation Studies in Health Informatics , 2009, Yearbook of Medical Informatics.

[3]  Maciek Sasinowski,et al.  What is mzXML good for? , 2005, Expert review of proteomics.

[4]  C. Holding.  Lab on a chip , 2004, Genome Biology.

[5]  Miguel García-Remesal,et al.  Building an Index of Nanomedical Resources: An Automatic Approach Based on Text Mining , 2008, KES.

[6]  F. Martín-Sánchez,et al.  Oligonucleotide microarray design for detection and serotyping of human respiratory adenoviruses by using a virtual amplicon retrieval software. , 2007, Journal of virological methods.

[7]  Jeffrey S. Morris,et al.  Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum , 2005, Bioinform..

[8]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[9]  Kristen L. Helton,et al.  Microfluidic Overview of Global Health Issues Microfluidic Diagnostic Technologies for Global Public Health , 2006 .

[10]  G H López-Campos,et al.  Analysis and Management of HIV Peptide Microarray Experiments , 2006, Methods of Information in Medicine.

[11]  Kevin Robbie,et al.  Nanomaterials and nanoparticles: Sources and toxicity , 2007, Biointerphases.

[12]  David B Warheit,et al.  Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  S. Bonnet,et al.  Chromatographic alignment combined with chemometrics profile reconstruction approaches applied to LC-MS data , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[14]  Fernando Martín-Sánchez,et al.  A Primer in Knowledge Management for Nanoinformatics in Medicine , 2008, KES.

[15]  Manolis Tsiknakis,et al.  An Integrated Clinico-Proteomics Information Management and Analysis Platform , 2008, 2008 21st IEEE International Symposium on Computer-Based Medical Systems.

[16]  J. Ioannidis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement , 2011, PLoS medicine.

[17]  Miguel García-Remesal,et al.  A Method for Indexing Biomedical Resources over the Internet , 2008, MIE.

[18]  Chris F. Taylor,et al.  A common open representation of mass spectrometry data and its application to proteomics research , 2004, Nature Biotechnology.